The Use of a Forecasting System for Predicting Exacerbations of COPD

November 30, 2010 updated by: AstraZeneca

The Use of a Forecasting System for Predicting Exacerbations of COPD: Effect on Symptoms and Hospitalisation and Relevance of Viral Infections

People with Chronic Obstructive Pulmonary Disease (COPD) often have periods during the year when their symptoms become worse. These are often due to an infection and are called "exacerbations" by doctors. Exacerbations are more common in the winter and also seem to be related to particular types of weather. As well as forecasting the weather the UK Met Office has developed a system to try to predict when exacerbations are likely to occur. The main purpose of this research study is to find out whether the Met Office forecasting service can predict when exacerbations are more likely to occur and whether the advice given during the predicted higher risk periods leads to fewer patients having an exacerbation or if it reduces the impact of the exacerbation. The study will also assess if there is a link between viral or bacterial infection and breathing problems that occur during the study period. The study will also collect information about possible causes of the breathing problems and what happens to the person afterwards. The results of this study will help us learn more about breathing problems which may lead to new research studies that would aim to improve the care of people with COPD.

Study Overview

Study Type

Interventional

Enrollment (Actual)

98

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Current or former smokers with a diagnosis of COPD
  • Having impaired lung function as measured by spirometry

Exclusion Criteria:

  • History of asthma or nasal symptoms caused by hayfever
  • No telephone
  • Inability to record symptoms in an electronic diary (PDA)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Forecast
COPD patients receiving advice and poor weather warning
Information leaflets on COPD and thermometers to monitor the ambient temperature in the bedroom and living room
Interactive automated telephone service to contact patients prior to anticipated periods of poor weather
Experimental: No Forecast
COPD patients receiving advice and poor weather warning
Information leaflets on COPD and thermometers to monitor the ambient temperature in the bedroom and living room
No Intervention: Control
Age matched non - COPD subjects

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The incidence and frequency of COPD exacerbations in each of the intervention groups
Time Frame: December 2008 to March 2009 inclusive
December 2008 to March 2009 inclusive
Electronic diary symptoms using the EXACT instrument
Time Frame: Daily recording
Daily recording

Secondary Outcome Measures

Outcome Measure
Time Frame
Medication usage and hospital admissions
Time Frame: Acutely
Acutely
Changes in the St Georges Respiratory questionaire
Time Frame: Start and end of study period
Start and end of study period
Severity and duration of exacerbations assessed using the EXACT instrument
Time Frame: Daily recording
Daily recording

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: David Halpin, MD, Royal Devon and Exeter Hospital, Exeter, Devon, UK

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Actual)

March 1, 2009

Study Completion (Actual)

March 1, 2009

Study Registration Dates

First Submitted

November 10, 2008

First Submitted That Met QC Criteria

November 10, 2008

First Posted (Estimate)

November 11, 2008

Study Record Updates

Last Update Posted (Estimate)

December 2, 2010

Last Update Submitted That Met QC Criteria

November 30, 2010

Last Verified

November 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)

Clinical Trials on COPD self care advice

Subscribe